Trials / Completed
CompletedNCT05512936
The Turkish Version of the Self-perceived Barriers for Physical Activity Questionnaire
Cross-cultural Adaptation, Reliability, and Validity of the Turkish Version of Self-perceived Barriers for Physical Activity Questionnaire
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 153 (actual)
- Sponsor
- Istanbul University - Cerrahpasa · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The Self-perceived Barriers for Physical Activity Questionnaire (SBPAQ) is originally developed in Spanish to evaluate self-perceived barriers for physical activity participation in healthy individuals. The purpose of this study is to translate and cross-culturally adapt the SBPAQ into Turkish and investigate its psychometric properties.
Detailed description
The Self-perceived Barriers for Physical Activity Questionnaire (SBPAQ) is originally developed in Spanish to evaluate self-perceived barriers for physical activity participation in healthy individuals. The purpose of this study is to translate and cross-culturally adapt the SBPAQ into Turkish and investigate its psychometric properties. Approximately two hundred healthy individuals aged between 18-65 years will be included. For cross-cultural adaptation, two bi-lingual translators will use the back-translation procedure. After the questionnaire will be translated into Turkish, the reliability, validity, and internal consistency of the Turkish version of SBPAQ (SBPAQ-T) will be tested. The questionnaire will be applied twice within 7 days to evaluate the test-retest reliability and to calculate the "Intraclass Correlation Coefficient" (ICC). Pearson correlation coefficient will be used to analyze construct and convergent/divergent validity. The construct validity of SBPAQ-T will be analyzed based on its correlation with the Physical Activity Barriers Questionnaire, International Physical Activity Questionnaire-Short Form, and Short Form-12. The Cronbach's Alpha will be calculated to determine internal consistency. The level of significance is considered as 0.05. The floor and ceiling effects will be detected.
Conditions
Timeline
- Start date
- 2022-11-25
- Primary completion
- 2022-12-30
- Completion
- 2023-01-21
- First posted
- 2022-08-23
- Last updated
- 2024-10-08
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05512936. Inclusion in this directory is not an endorsement.